Alcuni dei principali titoli Biotechnology attuali: Vertex Pharmaceuticals Inc (VRTX -1.19%), Moderna, Inc. Common Stock (MRNA -6.55%), Regeneron Pharmaceuticals Inc (REGN -2.98%), argenx SE American Depositary Shares (ARGX -3.93%).
La tabella seguente mostra un totale di 596 titoli Biotechnology, ciascuno dei quali contribuisce al panorama del settore Biotechnology. Puoi personalizzare facilmente la tabella classificando le azioni in base al prezzo, al volume o alla capitalizzazione di mercato in base alle tue specifiche preferenze di investimento.
Simbolo | Nome | Prezzo | Cap. di mercato | Volume | % (1D) | % (1M) | % (6M) | |
|---|---|---|---|---|---|---|---|---|
 Vertex Pharmaceuticals Inc | $542.50 | 137.54B | 2.45M | -1.19% | +7.75% | +27.84% | ||
 Moderna, Inc. Common Stock | $241.46 | 96.40B | 11.89M | -6.55% | +18.82% | +416.93% | ||
 Regeneron Pharmaceuticals Inc | $902.90 | 93.40B | 1.40M | -2.98% | +24.29% | +28.57% | ||
 argenx SE American Depositary Shares | $894.77 | 56.27B | 399.70K | -3.93% | -1.98% | +12.59% | ||
 BeOne Medicines Ltd. American Depositary Shares | $387.25 | 43.81B | 957.20K | +2.51% | +7.08% | +30.17% | ||
 Revolution Medicines, Inc. Common Stock | $177.65 | 38.08B | 7.77M | -11.04% | -14.46% | +20.68% | ||
 Genmab A/S ADS | $52.74 | 32.43B | 4.40M | -4.32% | +37.06% | +91.64% | ||
 Royalty Pharma plc Class A Ordinary Shares | $67.57 | 30.09B | 4.90M | +0.01% | +19.26% | +33.96% | ||
 Roivant Sciences Ltd. Common Shares | $36.62 | 26.45B | 9.68M | -4.21% | +2.35% | +29.31% | ||
 Incyte Genomics Inc | $118.01 | 24.05B | 1.60M | -3.94% | +3.40% | +21.07% | ||
 Insmed, Inc. | $108.76 | 23.86B | 2.62M | -1.13% | +4.75% | -22.00% | ||
 BioNTech SE American Depositary Share | $85.86 | 21.29B | 1.19M | -5.34% | -12.06% | -10.09% | ||
 Alnylam Pharmaceuticals, Inc. | $156.66 | 20.98B | 3.28M | -2.74% | -28.76% | -47.97% | ||
 Exelixis Inc | $68.71 | 16.77B | 4.60M | -5.55% | +16.75% | +54.68% | ||
 Ascendis Pharma A/S Ordinary Share | $253.45 | 16.68B | 558.07K | -1.74% | +11.15% | +12.50% | ||
 Jazz Pharmaceuticals, Inc. | $227.32 | 14.59B | 671.00K | -3.13% | -3.69% | +7.10% | ||
 BridgeBio Pharma, Inc. Common Stock | $74.27 | 14.47B | 3.39M | -4.65% | +12.29% | +7.98% | ||
 Halozyme Therapeutics, Inc. | $122.96 | 13.96B | 2.85M | -5.66% | +13.53% | +86.67% | ||
 Bio-Techne Corp. | $72.66 | 11.41B | 4.52M | -0.10% | +0.11% | +28.19% | ||
 Summit Therapeutics Inc. Common Stock | $14.19 | 11.32B | 5.95M | -12.24% | -17.83% | -19.10% | ||
 Kymera Therapeutics, Inc. Common Stock | $128.12 | 10.94B | 1.71M | -5.97% | +16.63% | +54.90% | ||
 BioMarin Pharmaceuticals Inc | $56.12 | 10.87B | 2.04M | -1.77% | -2.47% | +5.41% | ||
 Vaxcyte, Inc. Common Stock | $61.92 | 9.75B | 1.84M | -5.72% | -16.12% | +11.29% | ||
 Madrigal Pharmaceuticals, Inc. Common Stock | $400.10 | 9.29B | 859.74K | -0.08% | -18.95% | -20.37% | ||
 Spyre Therapeutics, Inc. Common Stock | $96.59 | 9.17B | 1.14M | -2.47% | +4.17% | +36.02% | ||
 Krystal Biotech, Inc. Common Stock | $300.25 | 8.90B | 401.55K | -3.41% | -10.33% | +5.51% | ||
 TG Therapeutics, Inc. | $57.98 | 8.87B | 2.11M | -5.92% | +7.55% | +60.61% | ||
 Protagonist Therapeutics, Inc | $135.26 | 8.75B | 583.89K | -5.66% | -3.82% | +36.34% | ||
 ImmunityBio, Inc. Common Stock | $8.01 | 8.49B | 12.52M | -10.30% | -22.83% | +5.67% | ||
 ARROWHEAD PHARMACEUTICALS, INC. | $57.46 | 8.12B | 1.81M | -6.80% | -7.84% | -23.32% | ||
 Twist Bioscience Corporation Common Stock | $120.61 | 8.00B | 3.06M | -15.41% | -41.17% | +112.72% | ||
 Corcept Therapeutics Inc. | $71.63 | 7.74B | 1.51M | -9.58% | -41.30% | +39.55% | ||
 Cytokinetics Inc. | $55.55 | 7.72B | 6.78M | -12.66% | -11.40% | -27.94% | ||
 Abivax SA American Depositary Shares | $84.18 | 7.37B | 1.23M | -5.94% | -8.24% | -32.00% | ||
 Caris Life Sciences, Inc. Common Stock | $26.03 | 7.36B | 7.83M | -21.64% | -14.35% | +37.36% | ||
 Praxis Precision Medicines, Inc. Common Stock | $262.59 | 7.33B | 313.85K | -7.80% | -7.40% | -21.22% | ||
 Rhythm Pharmaceuticals, Inc. Common Stock | $105.02 | 7.28B | 6.13M | -5.11% | +13.60% | +13.77% | ||
 Axsome Therapeutics, Inc | $129.80 | 6.83B | 1.11M | -5.26% | -26.70% | -41.81% | ||
 Ionis Pharmaceuticals, Inc. Common Stock | $38.80 | 6.45B | 2.97M | -3.36% | -10.80% | -48.44% | ||
 Oruka Therapeutics, Inc. Common Stock | $96.02 | 6.36B | 847.30K | -5.32% | +13.79% | +39.26% | ||
 Mirum Pharmaceuticals, Inc. Common Stock | $93.54 | 6.07B | 865.75K | -3.54% | +14.87% | -11.60% | ||
 Ligand Pharmaceuticals Inc. | $299.00 | 5.98B | 247.83K | -5.42% | -2.53% | +28.71% | ||
 Immunovant, Inc. Common Stock | $28.39 | 5.86B | 1.12M | -5.05% | -14.62% | +1.98% | ||
 Belite Bio, Inc American Depositary Shares | $143.19 | 5.77B | 223.68K | -7.03% | -10.05% | -7.25% | ||
 CG Oncology, Inc. Common stock | $64.80 | 5.74B | 931.81K | -4.30% | -5.69% | -3.54% | ||
 Kodiak Sciences Inc Common Stock | $91.02 | 5.72B | 1.10M | -7.60% | -2.97% | +113.36% | ||
 Scholar Rock Holding Corporation Common Stock | $45.50 | 5.54B | 1.45M | -1.28% | +4.84% | -3.47% | ||
 PTC Therapeutics, Inc. | $65.67 | 5.49B | 1.23M | -4.78% | +3.17% | +0.97% | ||
 Veradermics, Incorporated | $128.60 | 5.37B | 788.04K | -5.79% | +8.19% | +12.02% | ||
 Cogent Biosciences, Inc. Common Stock | $29.58 | 5.13B | 2.73M | -6.07% | -4.18% | -20.01% | ||
 CRISPR Therapeutics AG | $48.56 | 4.71B | 1.93M | -6.21% | -15.31% | -7.29% | ||
 Travere Therapeutics, Inc. Common Stock | $48.87 | 4.69B | 2.18M | -6.77% | -15.26% | +9.08% | ||
 Dianthus Therapeutics, Inc. Common Stock | $83.01 | 4.64B | 1.06M | -3.26% | -5.71% | -8.01% | ||
 Erasca, Inc. Common Stock | $13.27 | 4.64B | 6.70M | -11.00% | -9.85% | +32.83% | ||
 Legend Biotech Corporation American Depositary Shares | $22.54 | 4.38B | 3.23M | -1.01% | +20.05% | -20.94% | ||
 Edgewise Therapeutics, Inc. Common Stock | $38.87 | 4.22B | 5.05M | +3.57% | -3.55% | +2.26% | ||
 Definium Therapeutics, Inc. Common Shares | $30.36 | 4.08B | 1.92M | -7.16% | -16.20% | +35.54% | ||
 Relay Therapeutics, Inc. Common Stock | $17.00 | 3.73B | 4.73M | -5.71% | -12.33% | +30.77% | ||
 Acadia Pharmaceuticals Inc. | $21.24 | 3.66B | 6.03M | -1.07% | +5.62% | -4.97% | ||
 Xenon Pharmaceuticals Inc | $37.68 | 3.65B | 1.04M | -3.85% | +0.29% | -34.71% | ||
 AbCellera Biologics Inc. Common Shares | $11.13 | 3.61B | 4.06M | -9.36% | -19.23% | +138.84% | ||
 Tango Therapeutics, Inc. | $20.87 | 3.52B | 3.41M | -9.97% | -9.58% | -13.76% | ||
 Iovance Biotherapeutics, Inc. Common Stock | $7.74 | 3.51B | 23.34M | -11.03% | -45.30% | +94.47% | ||
 Disc Medicine, Inc. Common Stock | $78.47 | 3.48B | 931.02K | -5.78% | +23.91% | +16.10% | ||
 Parabilis Medicines, Inc. Common Stock | $27.88 | 3.44B | 922.42K | -8.17% | -5.59% | 0.00% | ||
 Arcutis Biotherapeutics, Inc. Common Stock | $27.00 | 3.39B | 7.61M | -20.70% | +7.36% | +15.29% | ||
 Tarsus Pharmaceuticals, Inc. Common Stock | $67.52 | 3.33B | 1.61M | -2.24% | -9.31% | +3.81% | ||
 Viking Therapeutics, Inc | $25.79 | 3.29B | 4.81M | -7.79% | -11.92% | -17.63% | ||
 Enliven Therapeutics, Inc. Common Stock | $44.79 | 3.28B | 1.61M | -5.21% | -1.50% | +7.72% | ||
 Viridian Therapeutics, Inc. Common Stock | $28.55 | 3.24B | 3.44M | -1.74% | +50.26% | +52.27% | ||
 Dyne Therapeutics, Inc. Common Stock | $17.36 | 3.24B | 3.21M | -6.36% | +12.44% | -0.63% | ||
 Telix Pharmaceuticals Limited American Depositary Shares | $9.42 | 3.20B | 328.16K | -2.59% | -13.42% | -14.67% | ||
 Denali Therapeutics Inc. Common Stock | $19.72 | 3.16B | 2.25M | -5.92% | -0.95% | +4.23% | ||
 Celcuity Inc. Common Stock | $64.04 | 3.13B | 1.10M | -7.51% | -13.01% | -54.80% | ||
 IDEAYA Biosciences, Inc. Common Stock | $30.65 | 2.96B | 1.24M | -5.28% | -19.47% | +6.42% | ||
 ADMA Biologics, Inc. | $13.21 | 2.96B | 15.02M | +26.05% | +30.66% | +28.88% | ||
 Zai Lab Limited American Depositary Shares | $22.60 | 2.81B | 815.55K | -0.88% | -11.79% | +7.72% | ||
 Beam Therapeutics Inc. Common Stock | $25.87 | 2.68B | 2.99M | -6.91% | +0.78% | -10.48% | ||
 Vericel Corporation | $51.78 | 2.65B | 2.68M | +13.85% | +26.08% | +40.67% | ||
 Xencor, Inc. | $34.05 | 2.53B | 1.43M | -2.80% | +32.85% | +164.98% | ||
 MBX Biosciences, Inc. Common Stock | $48.46 | 2.33B | 428.65K | -7.66% | -17.22% | +63.72% | ||
 Pharvaris N.V. Ordinary Shares | $32.53 | 2.28B | 907.15K | -5.24% | +6.69% | +8.36% | ||
 NewAmsterdam Pharma Company N.V. Ordinary Shares | $18.89 | 2.27B | 1.56M | -9.75% | -17.15% | -36.72% | ||
 Palvella Therapeutics, Inc. Common Stock | $156.85 | 2.26B | 269.78K | -3.35% | +18.68% | +21.15% | ||
 Arcus Biosciences, Inc. | $17.69 | 2.25B | 2.03M | -8.39% | -28.50% | -32.12% | ||
 Celldex Therapeutics, Inc | $28.27 | 2.22B | 1.11M | -5.55% | -13.26% | -16.51% | ||
 Lakefront Biotherapeutics American Depositary Shares | $33.56 | 2.21B | 343.08K | -1.55% | +13.72% | 0.00% | ||
 Septerna, Inc. Common Stock | $47.35 | 2.21B | 533.23K | -1.11% | +25.03% | +96.23% | ||
 Recursion Pharmaceuticals, Inc. Class A Common Stock | $3.50 | 2.18B | 25.26M | -9.79% | -26.78% | +3.86% | ||
 Aurinia Pharmaceuticals Inc | $16.21 | 2.17B | 1.14M | -5.26% | +3.12% | +1.06% | ||
 Vera Therapeutics, Inc. Class A Common Stock | $30.14 | 2.17B | 1.41M | -5.72% | +1.04% | -12.69% | ||
 Hemab Therapeutics Holdings, Inc. Common Stock | $45.57 | 2.13B | 456.91K | +1.06% | +48.97% | +82.28% | ||
 Immunome, Inc. | $17.91 | 2.11B | 2.21M | -8.27% | -15.42% | -22.52% | ||
 Biohaven Ltd. | $13.90 | 2.10B | 3.47M | -8.79% | +7.17% | +43.15% | ||
 Zymeworks Inc. | $28.74 | 2.07B | 1.22M | -7.13% | +9.63% | +7.70% | ||
 Fortrea Holdings Inc. Common Stock | $20.46 | 1.97B | 2.41M | -1.78% | -3.08% | +40.81% | ||
 First Tracks Biotherapeutics, Inc. Ordinary Shares | $45.43 | 1.91B | 570.37K | -7.36% | +37.71% | +114.39% | ||
 Harmony Biosciences Holdings, Inc. Common Stock | $32.47 | 1.91B | 1.48M | -5.65% | -18.66% | +0.40% | ||
 Replimune Group, Inc. | $20.02 | 1.90B | 4.00M | -3.24% | +52.24% | +597.56% | ||
 Vir Biotechnology, Inc. Common Stock | $11.02 | 1.86B | 2.93M | -6.37% | -6.45% | +10.09% | ||
 Sarepta Therapeutics,, Inc. Common Stock | $17.57 | 1.86B | 1.86M | -7.48% | +0.46% | -19.37% | ||
 Mesoblast Limited American Depositary Shares | $14.10 | 1.83B | 258.28K | -1.33% | -0.84% | -10.70% | ||
 Trevi Therapeutics, Inc. Common Stock | $12.81 | 1.83B | 1.58M | -8.40% | -6.63% | -12.62% | ||
 Maze Therapeutics, Inc. Common Stock | $32.53 | 1.81B | 643.89K | -2.55% | +23.08% | +22.48% | ||
 Zenas BioPharma, Inc. Common Stock | $25.93 | 1.69B | 822.61K | -8.89% | -6.83% | +24.90% | ||
 Stoke Therapeutics, Inc. Common Stock | $26.07 | 1.69B | 1.22M | -5.03% | +2.96% | -20.90% | ||
 Agios Pharmaceuticals, Inc. | $28.27 | 1.69B | 2.55M | -9.91% | -9.54% | +3.90% | ||
 Nurix Therapeutics, Inc. Common stock | $14.84 | 1.62B | 6.24M | -6.96% | -35.14% | -10.60% | ||
 Generate Biomedicines, Inc. Common Stock | $12.57 | 1.61B | 1.30M | -11.23% | -9.63% | -18.48% | ||
 Novavax Inc | $9.78 | 1.61B | 8.21M | -8.17% | -22.13% | +20.74% | ||
 Absci Corporation Common Stock | $9.39 | 1.61B | 5.12M | -10.40% | -18.56% | +67.38% | ||
 SELLAS Life Sciences Group, Inc. Common Stock | $7.88 | 1.59B | 10.69M | -13.79% | -32.24% | +61.81% | ||
 Ultragenyx Pharmaceutical Inc. | $15.57 | 1.59B | 5.38M | -9.27% | +7.38% | -37.74% | ||
 Kailera Therapeutics, Inc. Common Stock | $12.17 | 1.58B | 845.96K | -4.92% | +12.27% | -49.84% | ||
 Braveheart Bio, Inc. Common Stock | $17.42 | 1.57B | 1.59M | -13.38% | -18.43% | 0.00% | ||
 Intellia Therapeutics, Inc | $11.10 | 1.56B | 7.60M | -9.83% | -12.94% | -16.60% | ||
 Nanobiotix S.A. American Depositary Shares | $30.02 | 1.53B | 567.46K | +1.08% | +19.60% | -13.66% | ||
 Precigen, Inc. Common Stock | $4.22 | 1.51B | 26.69M | -16.52% | -45.48% | -2.54% | ||
 Lycia Therapeutics, Inc. Common Stock | $28.80 | 1.50B | 190.15K | -0.41% | 0.00% | 0.00% | ||
 uniQure N.V. | $21.01 | 1.47B | 3.94M | -8.77% | -7.85% | -0.71% | ||
 Nuvation Bio Inc. | $4.19 | 1.47B | 8.42M | -11.42% | -15.35% | -13.25% | ||
 Immunocore Holdings plc American Depositary Shares | $28.40 | 1.46B | 372.28K | -2.84% | -4.02% | -1.53% | ||
 Tyra Biosciences, Inc. Common Stock | $20.89 | 1.44B | 696.02K | -2.95% | -0.19% | -38.43% | ||
 ADARx Pharmaceuticals, Inc. Common Stock | $13.29 | 1.42B | 781.21K | -11.16% | -30.24% | -47.98% | ||
 Ascentage Pharma Group International American Depository Shares | $15.13 | 1.41B | 9,864 | +0.40% | +3.59% | -30.91% | ||
 Ocular Therapeutix, Inc. | $6.43 | 1.41B | 3.13M | -9.94% | -11.31% | -33.78% | ||
 Rapport Therapeutics, Inc. Common Stock | $23.72 | 1.41B | 707.46K | -8.52% | -26.31% | -33.35% | ||
 Innoviva, Inc. Common Stock | $19.24 | 1.39B | 2.65M | -9.50% | -6.78% | -15.06% | ||
 Korsana Biosciences, Inc. Common Stock | $30.43 | 1.39B | 110.23K | -0.43% | -0.94% | 0.00% | ||
 AnaptysBio, Inc. Common Stock | $45.58 | 1.36B | 381.49K | -4.06% | -7.36% | -34.21% | ||
 Structure Therapeutics Inc. American Depositary Shares | $19.08 | 1.36B | 1.01M | -6.29% | -30.84% | -53.58% | ||
 Damora Therapeutics, Inc. Ordinary Shares | $21.86 | 1.35B | 793.81K | -4.71% | +8.11% | -12.10% | ||
 Mineralys Therapeutics, Inc. Common Stock | $15.24 | 1.35B | 2.56M | -10.35% | -34.59% | -47.95% | ||
 Taysha Gene Therapies, Inc. Common Stock | $4.09 | 1.33B | 6.75M | -6.19% | -8.91% | -41.07% | ||
 Kardigan, Inc. Common Stock | $13.86 | 1.30B | 676.25K | -10.93% | -9.06% | 0.00% | ||
 GH Research PLC Ordinary Shares | $18.44 | 1.27B | 407.74K | -7.48% | -16.82% | -13.35% | ||
 UroGen Pharma Ltd. Ordinary Shares | $25.73 | 1.26B | 2.43M | -10.47% | -39.86% | +7.97% | ||
 Omeros Corporation | $17.07 | 1.24B | 991.87K | -6.11% | -9.68% | +15.57% | ||
 Nektar Therapeutics | $36.15 | 1.23B | 710.61K | -6.06% | -14.38% | -57.05% | ||
 Alpha Tau Medical Ltd. Ordinary Shares | $13.30 | 1.23B | 674.43K | -5.20% | -10.68% | +79.97% | ||
 LB Pharmaceuticals Inc Common Stock | $38.09 | 1.23B | 354.42K | -6.76% | +10.02% | +15.85% | ||
 Silence Therapeutics Plc American Depository Share | $19.72 | 1.23B | 1.40M | -0.40% | +94.48% | +176.19% | ||
 Mannkind Corporation | $3.76 | 1.21B | 5.40M | -4.33% | -1.57% | +31.47% | ||
 Avalyn Pharma Inc. Common Stock | $26.67 | 1.18B | 476.72K | -2.91% | -1.33% | -2.77% | ||
 Inhibrx Biosciences, Inc. Common Stock | $80.28 | 1.18B | 242.41K | -7.47% | -15.10% | -37.34% | ||
 Vor Biopharma Inc. Common Stock | $18.66 | 1.15B | 629.77K | -7.26% | +0.43% | +20.23% | ||
 SpyGlass Pharma, Inc. Common Stock | $34.08 | 1.14B | 192.28K | -1.07% | +33.18% | +39.61% | ||
 Verastem, Inc. | $9.38 | 1.14B | 3.03M | -4.77% | +17.25% | +57.38% | ||
 Seaport Therapeutics, Inc. Common Stock | $20.39 | 1.09B | 221.06K | -2.72% | +10.22% | +27.44% | ||
 Maravai LifeSciences Holdings, Inc. Class A Common Stock | $6.98 | 1.04B | 3.22M | -9.59% | -18.08% | +81.30% | ||
 Janux Therapeutics, Inc. Common Stock | $16.06 | 981.86M | 892.95K | -11.66% | -2.90% | +12.07% | ||
 Immatics N.V. Ordinary Shares | $6.18 | 940.75M | 1.28M | -10.56% | -20.05% | -43.56% | ||
 MoonLake Immunotherapeutics Class A Ordinary Shares | $10.80 | 919.15M | 1.32M | -6.57% | -5.10% | -36.51% | ||
 Odyssey Therapeutics, Inc. Common Stock | $18.88 | 907.52M | 434.53K | -3.18% | -9.40% | 0.00% | ||
 Savara Inc. | $4.38 | 899.91M | 3.45M | -6.01% | -8.37% | -16.57% | ||
 Jade Biosciences, Inc. Common Stock | $14.10 | 896.72M | 1.29M | -6.25% | +0.21% | -44.18% | ||
 Oric Pharmaceuticals, Inc. Common Stock | $8.49 | 880.01M | 1.39M | -9.10% | -32.03% | -11.29% | ||
 Monte Rosa Therapeutics, Inc. Common Stock | $10.25 | 874.46M | 1.50M | -5.27% | -0.19% | -47.03% | ||
 Pharming Group N.V. ADS, each representing 10 ordinary shares | $12.30 | 870.57M | 12,507 | -1.28% | +25.51% | -23.93% | ||
 Latigo Biotherapeutics, Inc. Common Stock | $13.01 | 862.55M | 424.86K | -7.34% | -21.77% | 0.00% | ||
 City Therapeutics, Inc. Common Stock | $17.07 | 859.17M | 210.24K | +4.02% | 0.00% | 0.00% | ||
 Alto Neuroscience Inc. | $21.87 | 858.22M | 411.27K | -6.14% | -8.91% | -14.07% | ||
 Inventiva S.A. American Depository Shares | $3.63 | 857.53M | 2.54M | -6.20% | +4.31% | -33.03% | ||
 Rigel Pharmaceuticals Inc. (New) | $45.71 | 853.86M | 553.30K | -10.88% | -4.35% | +62.73% | ||
 Syndax Pharmaceuticals, Inc. | $9.37 | 843.56M | 5.79M | -10.33% | -47.45% | -53.38% | ||
 Aktis Oncology, Inc. Common stock | $14.85 | 825.95M | 440.72K | -2.30% | -19.82% | -23.61% | ||
 Corvus Pharmaceuticals, Inc. | $9.73 | 818.50M | 1.15M | -7.95% | -9.40% | -38.03% | ||
 MeiraGTx Holdings plc Ordinary Shares | $8.51 | 817.33M | 688.57K | -9.66% | -22.07% | -12.72% | ||
 Bambusa Therapeutics, Inc. Common Stock | $15.85 | 807.44M | 421.57K | -1.37% | 0.00% | 0.00% | ||
 Prime Medicine, Inc. Common Stock | $4.45 | 807.13M | 4.75M | -10.46% | +38.63% | +31.27% | ||
 Annexon, Inc. Common Stock | $4.01 | 759.26M | 4.35M | -7.51% | -4.64% | -29.98% | ||
 Alumis Inc. Common Stock | $5.85 | 757.20M | 1.95M | -10.69% | -14.47% | -77.61% | ||
 Ardelyx, Inc. | $2.99 | 751.60M | 7.76M | -9.12% | -11.80% | -58.06% | ||
 Arbutus Biopharma Corporation Common Stock | $3.67 | 727.05M | 6.17M | -9.61% | -21.41% | -16.59% | ||
 Lexicon Pharmaceuticals, Inc. | $1.61 | 716.38M | 3.80M | +8.78% | -7.47% | -2.42% | ||
 OmniAb, Inc. Common Stock | $4.83 | 704.51M | 1.25M | -6.76% | -1.83% | +245.00% | ||
 Sana Biotechnology, Inc. Common Stock | $2.34 | 700.50M | 3.07M | -8.59% | -18.75% | -32.95% | ||
 Cullinan Therapeutics, Inc. Common Stock | $10.80 | 695.03M | 1.79M | -13.53% | -32.67% | -27.71% | ||
 Attovia Therapeutics, Inc. Common Stock | $15.00 | 684.77M | 376.78K | -3.85% | -16.64% | +3,081% | ||
 Ginkgo Bioworks Holdings, Inc. | $9.96 | 670.71M | 2.36M | -14.51% | -33.51% | +2.57% | ||
 Solid Biosciences Inc. Common Stock | $6.18 | 662.65M | 1.44M | -5.21% | -12.46% | -10.43% | ||
 Aura Biosciences, Inc. Common Stock | $6.34 | 657.49M | 791.18K | -4.66% | +1.93% | -28.76% | ||
 Achieve Life Sciences, Inc. | $6.38 | 657.28M | 1.81M | -8.67% | -9.06% | +39.80% | ||
 Sagimet Biosciences Inc. Series A Common Stock | $9.12 | 646.69M | 1.16M | -8.71% | +1.00% | +18.13% | ||
 Wave Life Sciences Ltd. Ordinary Shares | $3.22 | 635.08M | 5.33M | -11.05% | -14.13% | -55.15% | ||
 Zevra Therapeutics, Inc. Common Stock | $10.53 | 626.58M | 1.68M | -5.73% | -1.59% | -0.75% | ||
 Adlai Nortye Group Ltd. American Depositary Shares | $9.68 | 623.37M | 450.32K | +0.73% | -35.64% | -35.16% | ||
 4D Molecular Therapeutics, Inc. Common Stock | $11.25 | 621.50M | 1.60M | -8.39% | -12.93% | +15.86% | ||
 DBV Technologies S.A. American Depositary Shares | $9.80 | 615.84M | 415.48K | -1.41% | -6.13% | -49.72% | ||
 Candel Therapeutics, Inc. Common Stock | $8.04 | 615.21M | 1.23M | -11.16% | -21.41% | +4.82% | ||
 Helus Pharma Inc. | $8.39 | 613.05M | 1.43M | -3.34% | -26.53% | +60.73% | ||
 Nuvectis Pharma, Inc. Common Stock | $17.76 | 610.75M | 340.93K | -3.84% | -16.97% | +82.90% | ||
 Geron Corp | $0.9501 | 610.41M | 25.80M | -12.03% | -21.48% | -42.42% | ||
 Design Therapeutics, Inc. Common Stock | $9.67 | 605.16M | 751.93K | -9.03% | -22.14% | -27.89% | ||
 Kura Oncology, Inc. | $6.80 | 604.93M | 3.60M | -10.64% | -35.97% | -26.80% | ||
 ArriVent BioPharma, Inc. Common Stock | $12.23 | 603.03M | 1.10M | -9.34% | -57.03% | -59.00% | ||
 Immix Biopharma, Inc. Common Stock | $7.20 | 596.90M | 1.42M | -9.66% | -28.92% | -24.69% | ||
 Obsidian Therapeutics, Inc. Common Stock | $9.60 | 593.02M | 779.35K | -12.65% | -30.64% | 0.00% | ||
 Olema Pharmaceuticals, Inc. Common Stock | $6.76 | 591.48M | 1.71M | -10.34% | -18.06% | -53.83% | ||
 Apnimed, Inc. Common Stock | $14.16 | 589.49M | 447.80K | -7.45% | -34.90% | 0.00% |